Moreover, associations between antimicrobial resistance and presence of virulence genes in isolates of E. coli were investigated using the same analyses as in the case-control part of the study.
The placebo controlled part of the study was unable to assess vascular effects of infliximab due to early drop-out of the placebo group.
No effect was observed in the control group in either part of the study.
Immunization studies showing complete protection of all immunized subjects and infectivity in all control infections (in any part of the study), were included in a final dataset for analysis (Defined in Figure 1; listed in Table S1).
The characteristics of the patients and healthy controls included in this part of the study are shown in Table 3. Thirty-three percent (n = 29) of the patients where on antidepressants when blood samples were taken.
Control group for the tissue part of the study included 31 participants operated on due to benign gynecological pathologies not connected with endometrium and control group for the plasma part of the study included 14 women with no previous history of cancer or endometrial pathology.
ITA evaluates control and intervention subjects as part of the study groups to which they had originally been randomized.
In addition, 10 control houses that were also part of the study by Hald et al. (30 ) were matched and included for comparison in our study.
Due to the availability of maternal serum, the control group used for this part of the study was different from the cytokine analyzes performed (see Table III for demographic information).
Among mothers of cases 48.1 % and mothers of controls 24.8%% lived in rural part of the study area and most of mothers 93%% were currently married [Table 1].
In other control schools, staff expressed that being part of the study had benefitted them in other ways, and contributed to the school's status as a 'healthy school'.
